Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
American Pharma SummitAmerican Pharma Summit
Not Confirmed
Not Confirmed
18-19 November, 2024
Pharma Manufacturing 2...Pharma Manufacturing 2024
Not Confirmed
Not Confirmed
18-19 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
American Pharma SummitAmerican Pharma Summit
Industry Trade Show
Not Confirmed
18-19 November, 2024
Pharma Manufacturing 2...Pharma Manufacturing 2024
Industry Trade Show
Not Confirmed
18-19 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
14 Nov 2024
// ACCESSWIRE
https://www.accesswire.com/943008/aclarion-to-present-at-the-virtual-investor-summit-microcap-event-on-november-21st
10 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/10/2961153/0/en/Aclarion-to-Participate-in-the-2024-Maxim-Healthcare-Virtual-Summit.html
03 Nov 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/ert-and-bioclinica-become-clario-the-leading-technology-solutions-company-for-clinical-trial-innovation-and-evidence-301415313.html
15 Apr 2021
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/news/bioclinica-solution-clinical-trial-management/
01 Feb 2021
// Jenni Spinner OUTSOURCING-PHARMA
https://www.outsourcing-pharma.com/Article/2021/02/01/AI-based-image-redaction-guards-trial-patient-privacy
29 Jan 2021
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/news/bioclinica-module-ctms/
Details:
Under the terms of the agreement, Direct Biologics will leverage Bioclinica’s Interactive Response Technology (IRT) for their EXIT COVID-19 study, a multi-center FDA phase II clinical trial for the use of ExoFlo™ to treat COVID-19 acute respiratory distress syndrome (ARDS).
Lead Product(s): DB-001
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: ExoFlo
Study Phase: Phase IIProduct Type: Cell and Gene therapy
Sponsor: Direct Biologics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership September 09, 2020
Lead Product(s) : DB-001
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Direct Biologics
Deal Size : Undisclosed
Deal Type : Partnership
Details : Under the terms of the agreement, Direct Biologics will leverage Bioclinica’s Interactive Response Technology (IRT) for their EXIT COVID-19 study, a multi-center FDA phase II clinical trial for the use of ExoFlo™ to treat COVID-19 acute respiratory d...
Brand Name : ExoFlo
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
September 09, 2020
Inspections and registrations
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?